BRILLIANCE CHI(01114.HK):瀋陽中級人民法院指示於6月30日召開華晨債權人會議
格隆匯6月9日丨BRILLIANCE CHI(01114.HK)公吿,公司獲知會,於2022年6月2日,華晨及其若干相關企業已向瀋陽市中級人民法院提交重整計劃初稿,並提請召開有關表決重整計劃債權人會議。
公司獲進一步知會,於2022年6月8日,沈陽市中級人民法院指示於2022年6月30日召開華晨債權人會議。作為華晨債權人,集團若干成員公司已向華晨管理人作出有關其各自的債權人權利所需申報。
公司將繼續密切留意華晨重整發展,並將於適當時候另行發表公佈,以知會公司股東及公眾人士有關華晨重整任何重大發展。
繼續停牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.